Evidence mapPaperPMID 41606196Full record

ArticleThe EMBO journal2026

Molecular basis for the activation of Aurora A and Plk1 kinases during mitotic entry.

Anaïs Pillan, Philippine Ormancey, Celia Ben Choug, Stephen Orlicky, Nicolas Tavernier, Lucie Van Hove, Batool Ossareh-Nazari, Nicolas Joly, Frank Sicheri, Thierry Lorca and 1 more

Abstract read
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anaïs PillanUniversité Paris Cité, CNRS, Institut Jacques Monod, Paris, F-75013, France.ORCID http://orcid.org/0009-0003-0254-6365
Philippine OrmanceyUniversité Paris Cité, CNRS, Institut Jacques Monod, Paris, F-75013, France.
Celia Ben ChougCentre de Recherche de Biologie Cellulaire de Montpellier, UMR 5237, Université de Montpellier, CNRS, 1919 Route de Mende, 34293, Montpellier, Cedex 5, France.ORCID http://orcid.org/0009-0003-4582-7271
Stephen OrlickyThe Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada.
Nicolas TavernierUniversité Paris Cité, CNRS, Institut Jacques Monod, Paris, F-75013, France.ORCID http://orcid.org/0000-0001-7503-1758
Lucie Van HoveUniversité Paris Cité, CNRS, Institut Jacques Monod, Paris, F-75013, France.ORCID http://orcid.org/0000-0002-8499-5396
Batool Ossareh-NazariUniversité Paris Cité, CNRS, Institut Jacques Monod, Paris, F-75013, France.ORCID http://orcid.org/0009-0008-5368-6735
Nicolas JolyUniversité Paris Cité, CNRS, Institut Jacques Monod, Paris, F-75013, France.ORCID http://orcid.org/0000-0003-2731-3827
Frank SicheriThe Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada.ORCID http://orcid.org/0000-0002-9824-2117
Thierry LorcaCentre de Recherche de Biologie Cellulaire de Montpellier, UMR 5237, Université de Montpellier, CNRS, 1919 Route de Mende, 34293, Montpellier, Cedex 5, France.ORCID http://orcid.org/0000-0003-2007-8924
Lionel PintardUniversité Paris Cité, CNRS, Institut Jacques Monod, Paris, F-75013, France. lionel.pintard@ijm.fr.ORCID http://orcid.org/0000-0003-0286-4630

Funding

Agence Nationale de la Recherche (ANR) ANR-18-IDEX-0001Agence Nationale de la Recherche (ANR) ANR-22-CE13-0022Canadian Institutes of Health Research (CIHR) PJT-178026Fondation ARC pour la Recherche sur le Cancer (ARC) ARC 2023 PJA3Fondation ARC pour la Recherche sur le Cancer (ARC) ARCPJA2022050005002Ligue Contre le Cancer (laliguecancer) Equipe labélliséeLigue Contre le Cancer (laliguecancer) PhD FellowshipTerry Fox Research Institute (TFRI) TFRI-1107-04Université de Montpellier (UM) PhD fellowship
6 · The paper itself

Abstract

The evolutionarily conserved, intrinsically disordered protein Bora is critical for initiating the activation of mitotic kinases. Once phosphorylated at Ser112 by Cyclin A-Cdk1 kinase, phospho-Bora activates unphosphorylated Aurora A kinase (AURKA), directing it towards Polo-like kinase 1 (Plk1), thus promoting Cyclin B-Cdk1 activation and mitotic entry. Here, by combining structural modeling and in vitro assays, we provide evidence that Bora wraps around the N-terminal lobe of AURKA to position its phospho-Ser112 near AURKA's T-loop, mimicking T-loop phosphorylation. Additionally, Bora transiently interacts with the αC helix of the Plk1 kinase domain through a conserved motif, guiding AURKA activity towards the Plk1 T-loop, which is otherwise impervious to phosphorylation by AURKA. We highlight the importance of this motif for Bora function in vitro and during mitotic entry in Xenopus laevis egg extracts. Our results reveal critical molecular details of mitotic kinase activation, which could lead to the development of pathway-specific inhibitors.

Indexed as

Aurora Kinase ACell Cycle ProteinsMitosisProtein Serine-Threonine KinasesProto-Oncogene ProteinsXenopus ProteinsAnimalsEnzyme ActivationHumansModels, MolecularPhosphorylationPolo-Like Kinase 1Xenopus laevisAurora Kinase Abora protein, humanCell Cycle ProteinsPlk1 protein, XenopusPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsXenopus ProteinsAurora ABoraCell DivisionMitotic KinasesPlk1

Identifiers

PMID41606196
PMCPMC12953601

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.